Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

Prokidney (PROK) EBIT: 2022-2025

Historic EBIT for Prokidney (PROK) over the last 4 years, with Sep 2025 value amounting to -$38.5 million.

  • Prokidney's EBIT rose 21.31% to -$38.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$171.2 million, marking a year-over-year decrease of 9.53%. This contributed to the annual value of -$183.7 million for FY2024, which is 21.22% down from last year.
  • According to the latest figures from Q3 2025, Prokidney's EBIT is -$38.5 million, which was up 2.95% from -$39.7 million recorded in Q2 2025.
  • Over the past 5 years, Prokidney's EBIT peaked at -$20.7 million during Q2 2022, and registered a low of -$66.5 million during Q1 2022.
  • Its 3-year average for EBIT is -$41.3 million, with a median of -$40.9 million in 2023.
  • As far as peak fluctuations go, Prokidney's EBIT soared by 38.50% in 2023, and later slumped by 113.02% in 2024.
  • Quarterly analysis of 4 years shows Prokidney's EBIT stood at -$30.2 million in 2022, then increased by 19.93% to -$24.2 million in 2023, then plummeted by 113.02% to -$51.6 million in 2024, then grew by 21.31% to -$38.5 million in 2025.
  • Its EBIT stands at -$38.5 million for Q3 2025, versus -$39.7 million for Q2 2025 and -$41.4 million for Q1 2025.